Fortrea Holdings Inc (NAS:FTRE)

Fortrea Holdings Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 07:15PM GMT

Release Date Price: $17.37 (-5.60%)

Transcript

Taiye Opabunmi

JPMorgan - Analyst

Good morning, everyone. My name is Taiye Opabunmi and I'm delighted to welcome you to the 44 JPMorgan Healthcare Conference. Our next presenting company is Fortrea Holdings. It's -- they're leading global contract research organization dedicated to advancing clinical development and delivering innovative solutions that accelerate the path from molecule to medicine.

And I want you to welcome the CEO, Anshul Thakral, who will be leading the presentation today, and joined by the CFO, Jill McConnell, who will be helping with Q&A.

Anshul Thakrala

Fortrea Holdings Inc - President, Chief Executive Officer, Director

Thank you very much for the introduction, and thank you for hosting us. We appreciate it and we always enjoy spending time here at the conference. It's a great way to kick start the year for everybody. Okay. Before I get started, I want to welcome everyone, and thank everybody for joining us. And let me start briefly by showing the mandatory forward-looking statements.

And since all of you are

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.